DUXAP10 can promote CRC cell proliferation and tumorigenesis partly via epigenetically silencing p21 and PTEN transcription by binding to LSD1 and preventing LSD1-mediated the demethylation modification of target genes. The gene discussed is DUXAP10; the disease is colorectal carcinoma.